Form 4 for SONM DNA X, Inc.
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-23 · accession 0001493152-23-030021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-23 | 2023-08-23 | SONM | Liu Hao Peter | CEO, Dir | M - OptEx | $0.42 | +1.00M | 2.06M | +95% | +$420.0K |
| D | 2023-08-23 | 2023-08-23 | SONM | Liu Hao Peter | CEO, Dir | M - OptEx | $0.00 | -1.00M | 3.01M | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-23 | M | A | 1,000,000 | $0.42 | 2,057,831 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-08-23 | M | D | 1,000,000 | $0.00 | 3,014,419 | D | $0.42 · — to 2032-10-26 | 1,000,000 Common Stock | (F1) Consists of (i) 254,505 vested stock options and (ii) 2,759,914 stock options that will vest in eleven equal quarterly installments from October 14, 2023 to April 14, 2026. The options become exercisable upon vesting. |